Actively Recruiting
Blood And Tears in Alzheimer's Disease
Led by Danish Dementia Research Centre · Updated on 2024-08-22
600
Participants Needed
1
Research Sites
249 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.
CONDITIONS
Official Title
Blood And Tears in Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing lumbar puncture with cerebrospinal fluid available for analysis
- Diagnosed with Alzheimer's disease, Dementia with Lewy Bodies, Frontotemporal dementia, vascular dementia, or Normal pressure hydrocephalus
- Of legal age
- For control participants: lumbar puncture with cerebrospinal fluid available for analysis
- For control participants: no neurological disease
- For control participants: of legal age
You will not qualify if you...
- No lumbar puncture performed
- Clinically assessed as unfit to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Danish Dementia Research Centre
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
S
Steen G Hasselbalch, DMSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here